Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05027971 · ClinicalTrials.gov registry record
Flexiva Pulse Registry
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 201
- Enrollment target
NCT05027971: Completed study, sponsored by Boston Scientific Corporation.
NCT05027971 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05027971 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
To obtain post-market safety and efficacy data for FlexivaTM Pulse High Power Single-Use Laser Fibers during lithotripsy and soft tissue procedure of holmium laser enucleation of the prostate (HoLEP).
Primary Outcome
The primary safety endpoint is the occurrence of Serious Adverse Device Effects (SADE) related to Flexiva Pulse Laser Fibers during lithotripsy procedures.
Interventions
- DEVICE Flexiva Pulse High Power Single-Use Laser Fibers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2023-10-31 |
What the finished NCT05027971 record still lists
NCT05027971 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Flexiva Pulse High Power Single-Use Laser Fibers is the first listed.
NCT05027971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05027971 about?
NCT05027971 is a clinical study titled "Flexiva Pulse Registry". To obtain post-market safety and efficacy data for FlexivaTM Pulse High Power Single-Use Laser Fibers during lithotripsy and soft tissue procedure of holmium laser enucleation of the prostate (HoLEP).
What is the current status of trial NCT05027971?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2021-11-01. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT05027971?
The interventions under investigation include: Flexiva Pulse High Power Single-Use Laser Fibers (DEVICE).
Who is sponsoring clinical trial NCT05027971?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI